News - Page 3 of 6 - Cristal Therapeutics

Cristal Therapeutics appoints Dr Werner Cautreels as a new Director and Board Chairman and Andre Verwei as Chief Financial Officer

1st August 2019/in News /by Alex Jones

Maastricht, The Netherlands, 1stAugust 2019 – Cristal Therapeutics, a Phase 2 clinical stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announces that Dr Werner Cautreels is joining the Company’s supervisory board taking on the role of Chairman. Dr Cautreels succeeds Simon Sturge, who steps down […]

CRS

24th July 2019/in News /by Alex Jones

July 21–24 CRS Valencia, Spain

GapSummit

19th June 2019/in News /by Alex Jones

June 16-19 GapSummit Boston, USA

BIO2019

6th June 2019/in News /by Alex Jones

June 3-6 BIO2019 Philadelphia, USA

ASCO

4th June 2019/in News /by Alex Jones

May 31 – June 4 ASCO Chicago, USA

CIMT Annual Meeting

23rd May 2019/in News /by Alex Jones

May 21-23 CIMT 2019 Annual Meeting Mainz, Germany

Cristal Therapeutics to present data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on lead clinical candidate CPC634 in patients with solid tumors

17th May 2019/in News /by Alex Jones

Three poster presentations will be given by the company and its collaborators Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights important research findings Maastricht, The Netherlands, 17 May 2019 – Cristal Therapeutics, a clinical-stage pharmaceutical company developing […]